Literature DB >> 10391925

Stimulation of a vascular smooth muscle cell NAD(P)H oxidase by thrombin. Evidence that p47(phox) may participate in forming this oxidase in vitro and in vivo.

C Patterson1, J Ruef, N R Madamanchi, P Barry-Lane, Z Hu, C Horaist, C A Ballinger, A R Brasier, C Bode, M S Runge.   

Abstract

Thrombin is a potent vascular smooth muscle cell (VSMC) mitogen. Because recent evidence implicates reactive oxygen intermediates (ROI) in VSMC proliferation in general and atherogenesis in particular, we investigated whether ROI generation is necessary for thrombin-induced mitogenesis. Treatment of human aortic smooth muscle cells with thrombin increased DNA synthesis, an effect that was antagonized by diphenyleneiodonium but not by other inhibitors of cellular oxidase systems. This effect of thrombin was accompanied by increased O-2 and H2O2 generation and NADH/NADPH consumption. ROI generation in response to thrombin pretreatment could also be blocked by diphenyleneiodonium, suggesting that the NAD(P)H oxidase was necessary for ROI generation and thrombin-induced mitogenesis. Because of observed differences between the VSMC and neutrophil oxidase, we examined whether the cytosolic components of the phagocytic NAD(P)H oxidase were present in VSMC. p47(phox) and Rac2 were present in VSMC. Furthermore, thrombin increased expression of p47(phox) and Rac2 and stimulated their translocation to the cell membrane. We examined whether p47(phox) might be similarly regulated in vivo in a rat aorta balloon injury model and found that p47(phox) protein was increased after injury. Immunocytochemistry localized expression of p47(phox) to the neointima and media of injured arteries. Our data demonstrate that generation of O-2 and H2O2 is required for thrombin-mediated mitogenesis in VSMC and that p47(phox) is regulated by thrombin in vitro and is associated with vascular lesion formation in vivo.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10391925     DOI: 10.1074/jbc.274.28.19814

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  61 in total

Review 1.  Reactive oxygen intermediates involved in cellular regulation.

Authors:  B Meier
Journal:  Protoplasma       Date:  2001       Impact factor: 3.356

2.  H(2)O(2)-induced O(2) production by a non-phagocytic NAD(P)H oxidase causes oxidant injury.

Authors:  W G Li; F J Miller; H J Zhang; D R Spitz; L W Oberley; N L Weintraub
Journal:  J Biol Chem       Date:  2001-05-17       Impact factor: 5.157

3.  Complement-independent Ab-induced peroxide lysis of platelets requires 12-lipoxygenase and a platelet NADPH oxidase pathway.

Authors:  Michael Nardi; Steven J Feinmark; Liang Hu; Zongdong Li; Simon Karpatkin
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

Review 4.  Reactive oxygen species and vascular remodelling in hypertension: still alive.

Authors:  Shaoping Xu; Rhian M Touyz
Journal:  Can J Cardiol       Date:  2006-09       Impact factor: 5.223

Review 5.  Oxidative stress and atherosclerosis.

Authors:  P Christian Schulze; Richard T Lee
Journal:  Curr Atheroscler Rep       Date:  2005-05       Impact factor: 5.113

Review 6.  Basic mechanisms of oxidative stress and reactive oxygen species in cardiovascular injury.

Authors:  Christopher A Papaharalambus; Kathy K Griendling
Journal:  Trends Cardiovasc Med       Date:  2007-02       Impact factor: 6.677

7.  NADPH oxidase modulates myocardial Akt, ERK1/2 activation, and angiogenesis after hypoxia-reoxygenation.

Authors:  Jian-Xiong Chen; Heng Zeng; Qin-Hui Tuo; Heidi Yu; Barbara Meyrick; Judy L Aschner
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-01-12       Impact factor: 4.733

Review 8.  Cellular mechanisms and treatment of diabetes vascular complications converge on reactive oxygen species.

Authors:  Catharine I Whiteside
Journal:  Curr Hypertens Rep       Date:  2005-04       Impact factor: 5.369

Review 9.  Orchestrating redox signaling networks through regulatory cysteine switches.

Authors:  Candice E Paulsen; Kate S Carroll
Journal:  ACS Chem Biol       Date:  2010-01-15       Impact factor: 5.100

10.  Nox activator 1: a potential target for modulation of vascular reactive oxygen species in atherosclerotic arteries.

Authors:  Xi-Lin Niu; Nageswara R Madamanchi; Aleksandr E Vendrov; Igor Tchivilev; Mauricio Rojas; Chaitanya Madamanchi; Ralph P Brandes; Karl-Heinz Krause; Julia Humphries; Alberto Smith; Kevin G Burnand; Marschall S Runge
Journal:  Circulation       Date:  2010-01-18       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.